Karen Ven advances microfluidics for diagnostics and single‑cell analysis. She holds issued patents in microfluidic systems and droplet patterning, plus provisionals on dilution and cell sorting. With $3.4M PCR‑4‑ALL support, she develops modular, low‑cost platforms for scalable, ultrasensitive testing in public health.